Aardvark Therapeutics (AARD) Institutional Ownership $7.91 -0.29 (-3.54%) As of 09/9/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Aardvark Therapeutics (NASDAQ:AARD)Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$42.69MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$1.01M Get AARD Insider Trade Alerts Want to know when executives and insiders are buying or selling Aardvark Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data AARD Institutional Buying and Selling by Quarter Aardvark Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025Bank of America Corp DE7,989$108K0.0%+72.9%0.037% 8/15/2025Adage Capital Partners GP L.L.C.175,000$2.37M0.0%-30.0%0.806% 8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.3,091$42K0.0%N/A0.014% 8/13/2025New York State Common Retirement Fund7,300$99K0.0%N/A0.034% 8/8/2025Geode Capital Management LLC136,927$1.85M0.0%+129.7%0.631% 6/27/2025Goldman Sachs Group Inc.20,311$153K0.0%N/A0.094% 5/16/2025Goldman Sachs Group Inc.20,311$153K0.0%N/A0.094% 5/16/2025Cormorant Asset Management LP800,189$6.01M0.5%N/A3.688% 5/16/2025Adage Capital Partners GP L.L.C.250,000$1.88M0.0%N/A1.152% 5/15/2025Braidwell LP500,000$3.76M0.1%N/A2.305% 5/14/2025Walleye Capital LLC11,730$88K0.0%N/A0.054% 5/8/2025Decheng Capital LLC3,917,299$29.42M8.3%N/A18.055% (Data available from 1/1/2016 forward) AARD Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AARD shares? During the previous two years, 10 institutional investors and hedge funds held shares of Aardvark Therapeutics. The most heavily invested institutionals were Decheng Capital LLC ($29.42M), Cormorant Asset Management LP ($6.01M), Braidwell LP ($3.76M), Adage Capital Partners GP L.L.C. ($2.37M), Geode Capital Management LLC ($1.85M), Goldman Sachs Group Inc. ($153K), and Bank of America Corp DE ($108K).Learn more on Aardvark Therapeutics' institutional investors. Which institutional investors have been buying Aardvark Therapeutics' stock? Of the 10 institutional investors that purchased Aardvark Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Decheng Capital LLC ($3.92M), Cormorant Asset Management LP ($800.19K), Braidwell LP ($500K), Adage Capital Partners GP L.L.C. ($250K), Geode Capital Management LLC ($77.33K), Goldman Sachs Group Inc. ($40.62K), and Walleye Capital LLC ($11.73K). How much institutional buying is happening at Aardvark Therapeutics? Institutional investors have bought a total of 5,610,927 shares in the last 24 months. This purchase volume represents approximately $42.69M in transactions. Which of Aardvark Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Aardvark Therapeutics stock in the last 24 months: Adage Capital Partners GP L.L.C. ($75K). How much institutional selling is happening at Aardvark Therapeutics? Institutional investors have sold a total of 75,000 shares in the last 24 months. This volume of shares sold represents approximately $1.01M in transactions. Related Companies IMTX Major Shareholders OCS Major Shareholders GYRE Major Shareholders NAGE Major Shareholders VALN Major Shareholders BGM Major Shareholders VIR Major Shareholders GHRS Major Shareholders RLAY Major Shareholders KURA Major Shareholders This page (NASDAQ:AARD) was last updated on 9/10/2025 by MarketBeat.com Staff From Our Partners“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredWall Street Legend Issues Urgent AI Stock WarningChaikin's stepping forward with a new warning – focused on the red-hot A.I. frenzy taking the U.S. stock marke...Chaikin Analytics | SponsoredUnlock Friday's Full Potential: Two Simple Sentences that put profits in investors’ pocketsMost traders stick to the same routine each week. But a little-known market strategy has quietly delivered a 9...Eagle Publishing | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aardvark Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aardvark Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AARD Stock Alerts